Physician profile
Dalell Alia Zavala
NPI 1518321967
$1,100.40
in general payments reported to CMS, 2019-2025
9 companies · $224 in 2025
The $224 reported for 2025 was more than what 93% of Neonatal (Nurse Practitioner) providers received nationally (typical 2025 total: $40.24).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $468 · 2024: $408 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $289.50 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $121.81 | 2024 | Inpefa |
| Grifols USA, LLC | $115.75 | 2025 | Prolastin-C Liquid |
| Alnylam Pharmaceuticals INC. | $107.87 | 2025 | Amvuttra |
| Sumitomo Pharma America, INC. | $104.69 | 2023 | Gemtesa |
| Abbvie INC. | $104.07 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.57 | 2023 | Xifaxan |
| Biogen, INC. | $83.26 | 2024 | Skyclarys |
| Sanofi-Aventis U.S. LLC | $81.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalell Zavala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.